C Arnarez1, S J Marrink, X Periole. 1. Groningen Biomolecular Sciences and Biotechnology Institute and Zernike Institute for Advanced Materials, University of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands.
Abstract
The respiratory chain or oxidative phosphorylation system (OxPhos) generates most of the chemical energy (ATP) used by our cells. The cytochrome c oxidase (CcO) is one of three protein complexes of OxPhos building up a proton gradient across the inner mitochondrial membrane, which is ultimately used by the ATP synthase to produce ATP. We present molecular dynamic simulations of CcO in a mimic of the mitochondrial membrane, and identify precise binding sites of cardiolipin (CL, signature phospholipid of mitochondria) on the protein surface. Two of these CL binding sites reveal pathways linking CLs to the entrance of the D and H proton channels across CcO. CLs being able to carry protons our results strongly support an involvement of CLs in the proton delivery machinery to CcO. The ubiquitous nature of CL interactions with the components of the OxPhos suggests that this delivery mechanism might extend to the other respiratory complexes.
The respiratory chain or oxidative phosphorylation system (OxPhos) generates most of the chemical energy (ATP) used by our cells. The cytochrome c oxidase (CcO) is one of three protein complexes of OxPhos building up a proton gradient across the inner mitochondrial membrane, which is ultimately used by the ATP synthase to produce ATP. We present molecular dynamic simulations of CcO in a mimic of the mitochondrial membrane, and identify precise binding sites of cardiolipin (CL, signature phospholipid of mitochondria) on the protein surface. Two of these CL binding sites reveal pathways linking CLs to the entrance of the D and H proton channels across CcO. CLs being able to carry protons our results strongly support an involvement of CLs in the proton delivery machinery to CcO. The ubiquitous nature of CL interactions with the components of the OxPhos suggests that this delivery mechanism might extend to the other respiratory complexes.
Mitochondria are the intra-cellular organelles that produce most of the chemical energy
consumed by a cell and are therefore often refered to as the “power plant” of the cell. The
energy is produced through the oxidative phosphorylation (OxPhos) system. The OxPhos system is
embedded in the mitochondrial inner-membrane and consists of four large membrane protein
assemblies, the so-called “respiratory chain complexes” (i.e.: NADH quinone
oxidoreductase, complex I; cytochrome bc, complex III; cytochrome c
oxidase, complex IV; ATP synthase, complex V) and by some small electron carriers (quinones
and cytochrome c). Complexes I, III and IV operate a series of electron transfers whose
tortuous paths through the respiratory chain system is coupled with the translocation of
protons from the inside (matrix) to the mitochondrial intermembrane space (IMS), leading to an
electro-chemical gradient ultimately utilized by the ATP synthase to transform ADP into
ATP.Cardiolipin (CL), the signature phospholipid of mitochondrial membranes, has crucial
implications in mitochondrial processes, and on the OxPhos in particular12.
CLs are formed by two phosphatidyl-glycerol molecules linked by an additional glycerol moiety
and possess an anionic charge (−2 e). They are found in several parts of the
mitochondria and constitute about 10% of the phospholipids of, for instance, the bovine heart
mitochondrial inner membrane34. CL deficiency correlates with numerous
diseases5 including the Barth syndrome6 and heart failure7. Notably, the formation, stability, and function of individual respiratory chain
complexes and of respiratory chain supercomplexes strongly relies on the presence of CLs in
the membrane89101112. CLs bound to individual complexes have been
reported by several structural studies on various organisms131415, leading
to hypotheses on their possible involvement in a proton uptake pathway16 and/or
in assuring the structural integrity of individual complexes16171819 and
supercomplexes15.The focus of the present work is on bovinecytochrome c oxydase (CIV). It is a
transmembrane protein complex that consists of 13 subunits labeled A to M as depicted in Fig. 1A (The subunit's nomenclature following a roman number code as defined
by Kadenbach20 is given in Supplementary Information).
Primarily based on purification and delipidation by chromatography and binding affinity
assays1317182122 two classes of CL binding sites have been defined:
two sites with high-affinity and one to two additional sites with a lower affinity. The latter
have been associated with the structural integrity of CIV and of its dimeric form because
these CLs stabilize the subunits G and H (VIa and VIb according to Kadenbach nomenclature20), which are mandatory for the formation of the dimer1718. The
two CLs binding CIV with high affinity have been associated with the regulation of the
electron activity of the enzyme2122.
Figure 1
Structural characteristics of bovine heart cytochrome c oxidase (CIV).
(A) Structure of CIV with its thirteen subunits (A–M) shown in a cartoon representation
with a chain-based color-code for one monomer. The subunit's nomenclature following a
roman number code used in others studies20 is given in Supplementary Information. We kept on the letter code to avoid confusion with
the site names. In the bottom view of the dimer structure as found in the X-ray
structure CLs are depicted24. There are three CL binding sites per
monomer (CL1a, CL1b and CL2), with one facing the matrix side (CL2) and
two facing the intermembrane space (IMS; CL1a and CL1b). CL3 indicates the
location of an additional binding site suggested by photolabeling experiments19. (B) Simulation box for CIV system, with the protein shown in green, POPC
molecules in gray/white, CLs in red/orange and the aqueous phase in blue. (C) Structure
of a cardiolipin molecule in an atomistic (AA) and a coarse-grain (CG)
representation.
It is only with the most recent crystal structures of CIV2324 that CLs were
found bound to the protein. In the dimeric form of CIV four CLs co-crystallize with the
complex, defining three potential CL binding sites per complex (CL1a, b and CL2 in Fig. 1A) after consideration of the dimer's symmetry. The intuitive
assignment of the CL binding sites based on their location on the complex was in overall
agreement with the in-depth photolabeling study of Sedlak et al.19. The
low-affinity CL binding sites are located at the interface of the dimer and interact with
subunits G (CL1a/b in Fig. 1), while a high affinity binding site was
found on a more membrane exposed protein surface interacting with subunit J (CL2 in Fig. 1). There is however a CL binding site identified by Sedlak et
al.19 that is missing in the crystal structure (CL3 in Fig. 1).Here we explore the binding of CL to complex IV in a monomeric form by means of coarse-grain
molecular dynamics (CGMD) simulations. MD simulations have been successfully used to explore
the lipid/protein interplay2526 and more specifically lipid binding to a
variety of membrane proteins25272829303132. The use of a CG model
presents the advantage to investigate the lipid binding to proteins on much longer time scales
than conventional atomistic models and thus allows exploring the processes involved from a
more realistic dynamic perspective. We recently applied a similar approach to the study of CL
binding sites on the cytochrome bc15 in which case we have
characterized some key dynamic features of known CL binding sites and revealed a set of new
membrane-exposed binding sites potentially involved in the formation of supercomplexes.The set of CGMD simulations presented here clearly identified the precise positions of the
two CLs with high-affinity binding sites on CIV19. The lack of the low-affinity
binding sites expected at the interface of the dimer are not observed in the simulations,
which confirms that they are strongly associated with the dimer form of CIV and might only
exist with the dimer. Five additional CL binding sites with low-affinity are found and may be
easily rationalized in light of the position of other co-crystallized lipids24
and their common features. Most remarkably two of the binding sites are found located at the
matrix entrance of known proton uptake pathways (D and H). We show how the structure of the
protein reveals extensions of these pathways that directly link the CLs in these binding sites
to the entrance of the pathways. In the context of the ability of CL to trap protons our data
strongly support that CL maximizes CIV electron transport activity by providing protons to the
uptake pathways.
Results
Identification of seven CL binding sites on bovine heart cytochrome c
oxidase
We characterized the CL density around the protein from a 100 μs CGMD simulation of this
complex embedded in a POPC/CL (20/1 molar ratio) membrane. The average densities of CLs
(Fig. 2A) demonstrate the existence of several preferential sites
of interaction of CL with the protein. We define CL binding sites as the locations having
a CL density more than five times the bulk value. Accordingly, seven binding sites are
found on either leaflet of the membrane and are labeled I to VII (Fig.
2A). Sites I–V are on the matrix side of the membrane and sites VI and VII on the
side of the IMS. Sites V and VII may be occupied by two CLs and are therefore subdivided
into Va/Vb and VIIa/VIIb. A hierarchy of binding strength was observed, starting with many
CL binding/unbinding events for some sites (e.g. 380 exchanges for site VIIb) but
only few exchanges for others (e.g. few unbinding events for site I) during the
same amount of simulation time. For all sites but site I, binding events by at least 4 CLs
were observed (see Supplementary Movie), allowing us to extract
meaningful statistical averaged occupations and CL residence times listed in Table 1. The detailed structural characterization of the binding sites
is presented in Figure 2B-H.
Figure 2
Cardiolipin (CL) binding sites on cytochrome c oxidase (CIV).
Binding sites are extracted from a 100 μs of CGMD simulation of the complex embedded in
a CL/POPC membrane bilayer. (A) From left to right: matrix, membrane (two orientations)
and inter membrane space (IMS) views of CIV with the CL densities shown in yellow volume
maps at an isovalue corresponding to at least 5 times the bulk density. The protein is
shown as shaded grey cylinders with the CL densities projected onto them. (B–H) Detailed
description of the CL binding sites I to VII, respectively. The residues are numbered as
follows: “chain:residuesub-site”. For each site, the subunits involved in
the interactions with the CLs are depicted as colored cartoon as in Fig.
1. The rest of the protein is shown in a transparent gray cartoon.
Table 1
Occupation (Ξ) and residence time (θ, μs) of cardiolipin binding sites
on cytochrome c oxydase (CIV). The values are averaged over a 100 μs CGMD
simulation. The accuracy of the occupation levels is ±0.02 at most and of the residence
times within ±0.1 μs. See the Extended Methods given as Supplementary
Information for details. #CLs is the number of different CLs getting in contact
with a site and #events the number of binding/unbinding events. The lipids described by
Shinzawa-Itoh et al.24 (see Fig. 4) at the
locations corresponding to the CL binding sites found in the simulations are indicated in
the bottom row. The CL binding site predicted by Sedlák et al.19 at
the site II is also indicated
Site
I
II
III
IV
Va
Vb
VI
VIIa
VIIb
Ξ
0.99
0.60
0.57
0.36
0.74
0.68
0.52
0.88
0.50
θ
>50*
>60*
1.0
0.5
0.4
0.6
0.4
10.3
0.2
#CLs
1
4
17
11
20
10
13
4
20
#events
18
11
104
109
235
122
147
41
380
ref 19
–
CL
–
–
–
–
—
–
–
2DYR24
CL
TGL2
PE3
PE1
TGL3
TGL3
—
TGL1
TGL1
*The strong binding of CLs in sites I and II led to poor binding/unbinding
events statistics and prevented us from determining accurate residence time.
Instead we indicate a rough estimate obtained from the binding behavior. See
Figure S1 in Supplementary
Information.
Site I quickly bound a single CL that remained bound during the entire simulation
although reorientation of the CL led to multiple short unbinding events (see Supplementary Figure S1). These events complicated the computation of the
lifetime estimated at more than 50 μs (Table 1). In this site the
CL mainly interacts with the subunit C and with a couple of residues of subunit J (Fig. 2B). Sites II and III are adjacent to site I and located at the
junction of subunits A and L and subunits C and G, respectively (Fig.
2C–D). They both bind one CL at a time and have slightly lower occupancies (60%)
than site I. Although it is difficult to precisely determine the time scale of CLs binding
to site II (see Supplementary Fig. S1; estimate ~60 μs) it is
significantly longer than in site III in which CLs exchange on a time scale of ~1 μs. Site
IV is located on the face of CIV that corresponds to the dimer interface in the crystal
structure. This site, involving subunits A and C, is occupied only 36% of the time and CLs
bind on a sub-microsecond timescale. Site V is located at the other extremity of CIV as
compared to site I. CLs in site Va and Vb interact with subunits B, E and I, and A and B,
respectively. They have similar occupancies, ~70%, and similar residence times, ~0.5 μs.
Site VI is located on the IMS side of CIV. It involves the C-termini of subunits L and M,
has a low CL occupancy, 50%, and a small CL residence time, ~0.4 μs. Site VII is located
on the same protein surface as site V, but on the opposite leaflet (IMS). CLs in site VIIa
and VIIb primarily interact with subunits A, B, D and I on the IMS side of the protein.
Site VIIa is significantly more occupied (88%) than site VIIb (50%) and has a relatively
long residence time of ~10 μs. The difference between sites VIIa and VIIb might reflect
that site VIIa is buried deeper in a cavity formed by helices of subunits B and I, whereas
site VIIb is more exposed to the membrane.We further characterized the binding strength of CL to CIV by determining the potentials
of mean force (PMFs) of CL's binding to a selection of the sites (Fig.
3). The data clearly indicates that CL's binding to site I and II is stronger
than to the other sites. Site III was taken as a reference site because it is relatively
well occupied, accessible to the membrane and explored by many CLs so that the statistics
obtained is reliable (Table 1). The data also indicate that CL
binds similarly to site II than to site I. The comparison of the PMFs of a CL binding to
site II with or without the −2 e charge of its headgroup indicates that although
the charge of the headgroup bears the most significant contribution to the binding, the
tails also contribute to CL's binding strength. The contribution from the CL's bulky tail
is by itself larger than the binding strength of a POPC molecule.
Figure 3
Potential of mean force for binding of various lipids to sites I, II and III.
(A) Comparison of CL's binding strength to site I (cyan), II (blue) and III (green).
(B) Comparison of binding strength of TGL (yellow), POPC (orange) and CL to site II. Two
CLs were tested; double charged (−2 e) and neutral, blue and green curves,
respectively. In both panel the relative free energy of the system is expressed as a
function of the distance, dCOM, between the center of masse of the lipid
headgroup and of the binding site as defined in Fig. 2. The error
on the measure (estimated using the Bayesian bootstrapping method) is shown by the
shaded area behind the curves.
Residue content of the binding sites
Interesting features emerged from the analysis of the residues in contact with CLs during
the 100 µs simulation (Fig. 4). First, all the residues that made at
least one contact with a CL molecule virtually span the entire transmembrane region of the
protein, indicating that the CLs explored the complete transmembrane protein surface. As
expected, the distribution of contacts as a function of the residue type (grey bars in
Fig. 4) is in general agreement with the amino acid distribution
in integral membrane proteins33 keeping in mind that a residue would need
to be exposed to the membrane to be in contact with a CL. Furthermore, focusing on the
composition of the CL binding sites (black bars in Fig. 4), the
positively charged amino acids (lysine and arginine) were found to account for ~25% of the
CL ligands. The large contribution from positively charged residues might be expected
since CL carries a −2 e charge and is illustrated by the strong correlation between
the locations of the CL's binding sites with the positive regions of electrostatic
potential on the protein's surface (Fig. S2). Lysine is slightly
favored over arginine (14 vs 11%), which contrasts with the results obtained previously
for CIII15. In that case arginine was significantly more represented in the
binding sites than lysine, which then represented only ~5% of the CL's ligands against 18%
for arginine. Phenylalanine and leucine were found to be a relatively important
contribution to the CL binding sites (> 10%) in both CIII and CIV.
Figure 4
Residue content of the CL binding sites of cytochrome c oxidase (CIV).
The gray sticks indicate the percentage of each residue type at least once in contact
with a CL; e.g. present in the section of the CIV accessible to CLs. The black
sticks give for each residue type the percentage of its participation to the CL binding
sites.
Discussion
A thorough analysis of the lipids bound to CIV was presented by Shinzawa-Itoh et
al.24 combining a crystal structure of the complex with mass
spectroscopy. They discussed up to seven species of lipids per monomer of CIV among which
three CLs, three phosphatidylethanolamines (PEs), four phosphatidylglycerols (PGs) and three
triglycerides (TGLs). These lipid types are found in the native mitochondrial inner
membrane3 (TGL only recently24) and their presence in the
crystal is therefore not expected to be an artifact of the crystallization process. Their
positions are depicted in Figure 5 together with the CL binding sites
found in the simulations. The comparison of the two sets of molecules allows to
unambiguously identifying the two CL binding sites with high-affinity and involved in CIV's
proton transport activity, and suggesting the most likely candidates for the low-affinity
binding sites that have been linked to CIV's structural integrity. Our interpretation is in
complete agreement with earlier predictions of Robinson and co-workers131922.
Figure 5
Location of the co-crystallized phospholipid positions and densities computed with
our CGMD simulation.
The experimental positions (upper part) were extracted from the PBD entry 2dyr24. The densities (lower part) are extracted from the 100 μs CGMD simulation.
Views from the matrix (left) and the IMS (right) sides of CIV are shown. CL:
cardiolipin; PC: phosphatidylcholine; PE: phosphatidylethanolamine; PG:
phosphatidylglycerol; TGL: triglyceride.
Among the three CL binding sites per monomer found in the dimer structure of CIV2324 (CL1a, b and CL2 in Fig. 5), only CL2 is observed in
the simulations. It is located at the site I. This site is filled early in our simulation
and remains occupied during the entire simulation (Table 1 and Supplementary Fig. S1), which gives it one of the highest binding
affinities observed in the simulations. This result is in agreement with its presence in the
crystal structure and the PMFs described above, and confirms that it corresponds to one of
the high-affinity sites as predicted by Sedlák et al.19. CL1a/b,
located at the dimer interface in the crystal structures2324, are not
stable in our simulations of CIV as a monomer. These two CLs have been suggested to be the
ones loosely bound to CIV and strongly connected to the existence of the dimeric form of CIV
by their stabilization of subunits G and H1819. Our simulations indicate
that the tight association of CIVs in the dimer is a determinant factor for the stability of
CL1a and CL1b. To test this hypothesis, additional simulation of the dimeric
structure of CIV including the experimental CL1a/CL1b were performed. Both sites were found
stable on the μs time scale.The site II defined by the simulations (Fig. 2 and 5) confirms the location of the second high-affinity CL binding site predicted by
Sedlák et al.19 using photolabeling and missing in the crystal
structures (CL3 in Fig. 1). The relatively low occupancy and residence
time (Table 1) might be surprising at first but reflect that it took
~40 μs for a CL to enter the protein cavity forming the binding site (see Supplementary Fig. S1). Once the CL made the proper contacts the site is fully
occupied and therefore corresponds to a high-affinity binding site. This result is
corroborated by the PMF of CL binding to site II, which shows a similar bonding strength to
site I (Fig. 3A). It is interesting to note that a TGL (TGL2 in Fig. 5) occupies the site II in the crystal structure24.
From our understanding of the system it is extremely unlikely that both CL and TGL molecules
occupy site II. The PMFs of the binding of a CL vs. a TGL (Fig.
3B) demonstrate not only that CL binds much stronger but also that TGL is no stable
in site II. Unrestrained simulations confirm this observation: a TGL placed in site II left
it quickly and went to mix with the bulk after exploring the surrounding of the protein
surface around the site. The PMFs showed that an important part of the CL's binding strength
is due to coulombic interactions, which might rationalize the weak binding of TGL; it is a
neutral molecule. It is not clear at this point why a TGL molecule is present in the crystal
although it was argued not to be an artifact of the purification24. One might
speculate that the TGL molecule had the capability to replace the CL using the similarity of
their bulky tails. This scenario implies however that the CL was first destabilized, which
might occur by disruption of the interaction of its headgroup during the crystallization
process. Note the PMFs showed a neutral CL still binds site II stronger than TGL suggesting
that TGL's bulky tails are not sufficient to stabilize it. See the Supplementary Information for additional discussion on the presence of TGL
molecules in CL's binding sites.The remaining CL binding sites (III–VII) found in the simulations are relatively weak
binders and unless they are buried within a large protein cavity (sites Va and VIIa) they
have a low occupancy. They all correspond to the location of binding of another lipid type
in the crystal, which is in line with previous studies showing the conservation of binding
sites by different lipid types14. We review the several cases observed in CIV
and show that it is quite straightforward to rationalize the discrepancies from the
similarities of CLs with PGs and TGLs (CL and PG share a negatively charged headgroup, while
CL and TGL bulky tails), see Supplementary Information for more detailed
discussion.The high degree of conservation of lipid binding sites on CIV from various organisms14 suggests an important functional role of these bound lipids. CLs have been
shown to affect CIV in two ways. First, there is extensive data demonstrating that the
presence of two CLs with high-affinity binding to CIV, which we have shown are bound in site
I and II, is mandatory for a fully functional CIV22. It is however unknown by
which mechanism they operate. CIV enzymatic activity is often summarized by its electron
transport activity (up take from cytochrome c) but CIV uses as many protons as
electrons to transform a dioxygen molecule into two water molecules. CLs have the ability to
trap protons34 and thereby can facilitate proton translocation along the
membrane surface35. This particular feature of CL has been suggested to be an
important aspect of CIII mechanism for proton transfer163637 and might
extend to CIV by providing proton sources to either of the D-, K- or H-pathways38394041. The proximity of CL3 to the D-pathway entrance has suggested that
CL might be acting as a proton antenna to this pathway19 although only
limited structural insight is available since this site is not occupied in the crystal
structures2324.Our data confirm that this ability of CL to carry protons is indeed relevant to site II but
might also be to site Vb. Both sites are located on the matrix side of the IM where the
protons are taken up. Site II corresponds to CL3 (Fig. 1, 5) and is very close to the D-pathway entrance (~1.1 nm; Fig. 6), while site Vb is close to the entrance of the H-pathway (~0.8 nm; Fig. 6). Up to now residues A:D91 (A:D132 in Rodobacter
sphaeroides) and A:D407 define the matrix side entrances to the D- and H-pathways,
respectively. Only little is known on the proton path before these residues. A close
inspection of the protein structure revealed in both cases the existence of a strong H-bond
network starting at the CL binding sites II and Vb and leading to the entrances of the D-
and H-pathways, respectively (Fig. 6). These networks form clear
extensions of the D- and H-pathways towards the exterior of the protein on the matrix side.
They directly connect the CL binding sites to A:D91 (A:D132 in Rodobacter
sphaeroides) and A:D407, respectively, and thereby strongly support the idea that CLs
provide a source of protons at the surface of the membrane facilitating CIV electron
transport activity.
Figure 6
H-bond networks leading from the cardiolipin (CL) binding sites to the entrance of D-
and H-pathways, A:D91 and A:D407, respectively.
The CL binding sites are shown in stick representation. The yellow surface maps depict
the CL densities shown in Fig. 2. A:D91 and A:D407 are shown in
large sticks. The residues and water molecules (red spheres) participating to the
networks are shown in a ball-and-stick representation and numbered as in Fig. 2. The bottom row shows side and top views of CIV with the CL densities,
the residues involved in the sites in blue, the residues involved in the transmembrane
section of the proton pathways (red arrows) in orange spheres and the heme molecules in
green. The large red spheres position the entrances (A:D91 and A:D407) of the
pathways.
It is also notable that up to four CLs occupy the protein cavity close to the H-pathway;
two lipids in sites Va/b and VIIa/b on the matrix and IMS side of the membrane,
respectively. This aggregation of CLs might be relevant to the ‘dielectric channel' activity
of CIV proposed by Rich42.The second way by which CLs affect CIV is by providing structural integrity. Two additional
CLs, which we propose being CL1a and CL1b in the crystal structures (Fig. 1, 5), serve the structural integrity of CIV by
stabilizing subunits G and H, and thereby its dimeric form17. These two CLs
have been shown to bind CIV with a low-affinity19 and are not observed in the
simulation of the monomeric form of CIV (Fig. 2) but are stable in the
dimeric structure. This ability of CLs to stabilize CIV dimers can be extended to high-order
oligomers of the respiratory chain complexes as it was reported in the context of the
formation of supercomplexes. This behavior is most notable for the formation of
supercomplexes CIII2-CIV and CIII2-CIV2912. Our recent CGMD simulations of the CIII15 suggested that CL binding sites
on the surface of the complex might define the location of protein-protein contact with CIV.
The CL binding sites found on CIV might share a similar function.In summary, the CGMD simulations used in this study to investigate the CL binding sites on
the respiratory chain complex IV, cytochrome c oxidase, provide new and valuable
insights on the way CLs participate to the function of proteins. The locations of the CL
binding sites that most likely correspond to both the high and low-affinity CL binding to
CIV are identified with high level of confidence. They agree with and reconcile all known
experimental data. CL binding sites on the surface of the protein are found at the proximity
of two of the three known proton-uptake pathways, the D- and H-pathways. Two clear
interaction networks connecting the CL binding sites to the entrances of these two pathways
are uncovered. To our knowledge they provide the first complete proton pathway between the
membrane surface (CL binding sites) and the D- and H-pathways in cytochrome c
oxidase. This data strongly supports that CLs take active part in the proton delivery
mechanism. Given the wide impact of CL in the respiratory chain machinery the role suggested
by our data should extend to other components of the respiratory chain.
Methods
Molecular models
The Protein Data Bank (PDB) entries 1occ and 2occ38 were used to
built a complete atomistic model of CIV, which was simulated as a monomer, its functional
form. In the experimental dimeric structure of CIV24 four CLs
co-crystallize with the protein (Fig. 1A). In a monomeric
configuration, the experimental CL positions are all exposed to the membrane bulk and were
not included in the initial conformation. In the simulations, the complex lipid
composition of the mitochondrial membrane was modeled by a two components mixture of
CL:POPC with a molecular ratio of 1:20 (5% of CL, 10% of total phosphorus content). This
value is close to the experimental molecular ratio observed for bovine heart mitochondria
(15 to 20% of the phosphorus content3).The systems were described with the Martini CG force field for biomolecules (version
2.043) and its extension to proteins (version 2.144)
together with the ElNeDyn approach45. The Martini force field defines
chemical groups as CG beads (or super-atoms) parameterized to reproduce known
thermodynamical observables associated to these groups. Molecules are constructed from
these super-atoms using conventional bond, angle and dihedral potentials such that they
reproduce the structure and flexibility of atomistic models4344. ElNeDyn
maintains the secondary and tertiary structures of CG proteins through an elastic network.
In our model, each subunit is maintained independently, so that domain motions
(reorientation of subunits) are possible. CG parameters for CLs and TGLs were taken from
the works of Dahlberg et al.46 and Vuorela et al.47.
Simulation details
All CG simulations were performed using the GROMACS simulation package version 4.048. Conventional simulation setups associated with the use of Martini and
ElNeDyn were used. The protein, membrane bilayer (POPC and CL) and aqueous phase (water
and Na+ ions) were coupled independently to an external temperature
bath49 at 300 K and the pressure was weakly coupled to an external
bath49 at 1 bar using a semi-isotropic pressure scheme. Further details
of the models, simulation protocols and limitations, as well as the methods used for
analysis, are published as Supplementary Information.The CG protein structure was inserted into a pre-equilibrated CL:POPC membrane patch. The
system was energy minimized and simulated for 10 ns with position restraints on the
backbone beads of the protein to relax the solvent and side-chains before starting
production runs. The system shown in Fig. 1B contains the protein
(1780 residues; 4117 beads), a POPC bilayer (966 lipids; 12,558 beads) including CLs (48
CLs; 1296 beads) and the aqueous phase (51,549 water beads and 103 sodium ions).The potentials of mean force (PMF) of lipid molecules binding to CIV binding sites were
computed using an umbrella sampling approach with the distance to the protein surface as
reaction coordinate. Details are given as Supplementary
Information.
Author Contributions
C.A. conducted the simulations. X.P. and C.A. built the models and analysed the
trajectories. X.P., C.A. and S.J.M. designed the models and simulations. X.P., C.A. and
S.J.M. interpreted the data and wrote the paper.
Authors: Lars V Schäfer; Djurre H de Jong; Andrea Holt; Andrzej J Rzepiela; Alex H de Vries; Bert Poolman; J Antoinette Killian; Siewert J Marrink Journal: Proc Natl Acad Sci U S A Date: 2011-01-04 Impact factor: 11.205
Authors: T Tsukihara; H Aoyama; E Yamashita; T Tomizaki; H Yamaguchi; K Shinzawa-Itoh; R Nakashima; R Yaono; S Yoshikawa Journal: Science Date: 1996-05-24 Impact factor: 47.728
Authors: John J Maguire; Yulia Y Tyurina; Dariush Mohammadyani; Aleksandr A Kapralov; Tamil S Anthonymuthu; Feng Qu; Andrew A Amoscato; Louis J Sparvero; Vladimir A Tyurin; Joan Planas-Iglesias; Rong-Rong He; Judith Klein-Seetharaman; Hülya Bayır; Valerian E Kagan Journal: Biochim Biophys Acta Mol Cell Biol Lipids Date: 2016-08-04 Impact factor: 4.698
Authors: E Madison Sullivan; Amy Fix; Miranda J Crouch; Genevieve C Sparagna; Tonya N Zeczycki; David A Brown; Saame Raza Shaikh Journal: J Nutr Biochem Date: 2017-04-12 Impact factor: 6.048